Status
Conditions
About
The purpose of this study is to determine if a liquid biopsy, a method of detecting cancer from a blood draw, combined with a PET/CT scan, a type of radiological scan, is better at determining whether a lung nodule is cancerous when compared to a PET/CT scan alone. A PET/CT scan is already used for diagnosis of lung nodules, but its efficacy is uncertain in nodules 6-20 mm in size. Therefore, the PET/CT will be evaluated for its diagnostic ability in lesions this size alone and in combination with a liquid biopsy. Secondarily, a machine learning model will be created to see if the combination of the PET/CT imaging data and the liquid biopsy data can predict the presence of cancer.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Over 18 years of age
ECOG performance status of 0,1, or 2
Newly discovered lung nodule with:
Able to provide informed consent
Exclusion criteria
31 participants in 1 patient group
Loading...
Central trial contact
Rajesh Shah, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal